Jean Pierre Zellweger

Summary

Country: Switzerland

Publications

  1. ncbi Latent tuberculosis: which test in which situation?
    Jean Pierre Zellweger
    Department of Ambulatory Care and Community Medicine, University of Lausanne, Switzerland
    Swiss Med Wkly 138:31-7. 2008
  2. pmc Accelerated decline in lung function in smoking women with airway obstruction: SAPALDIA 2 cohort study
    Sara H Downs
    Institute of Social and Preventive Medicine, University of Basle, Basle, Switzerland
    Respir Res 6:45. 2005
  3. ncbi Active and passive screening for tuberculosis in Vaud Canton, Switzerland
    Murielle Monney
    University Medical Policlinic, Lausanne, Switzerland
    Swiss Med Wkly 135:469-74. 2005
  4. ncbi Current issues in the management of tuberculosis in Europe
    J P Zellweger
    Swiss Lung Association, Berne, Switzerland
    Panminerva Med 55:145-55. 2013
  5. doi [Multidrug resistant tuberculosis -- its extent, hazard and possible solutions]
    J P Zellweger
    Centre de compétence tuberculose, ligue pulmonaire suisse, 14c, Südbahnhofstrasse, 3000 Berne 14, Suisse
    Rev Mal Respir 28:1025-33. 2011
  6. pmc Reference values for methacholine reactivity (SAPALDIA study)
    Pierre Yves Jayet
    Service of Pulmonology, University Hospital Lausanne, Switzerland
    Respir Res 6:131. 2005
  7. pmc Clinical presentation, demographics and outcome of tuberculosis (TB) in a low incidence area: a 4-year study in Geneva, Switzerland
    Omar Kherad
    Department of Internal Medicine Geneva University Hospitals and University of Geneva, Geneva, Switzerland
    BMC Infect Dis 9:217. 2009
  8. ncbi Tobacco and tuberculosis
    J P Zellweger
    Department of Aambulatory Care and Community Medicine, University of Lausanne, Switzerland
    Monaldi Arch Chest Dis 69:83-5. 2008
  9. ncbi Bupropion SR vs placebo for smoking cessation in health care professionals
    Jean Pierre Zellweger
    University Medical Policlinic, 10011 Lausanne, Switzerland
    Am J Health Behav 29:240-9. 2005
  10. ncbi Intra-observer and overall agreement in the radiological assessment of tuberculosis
    J P Zellweger
    University Medical Outpatient Department, University Hospital, Lausanne, Switzerland
    Int J Tuberc Lung Dis 10:1123-6. 2006

Collaborators

Detail Information

Publications48

  1. ncbi Latent tuberculosis: which test in which situation?
    Jean Pierre Zellweger
    Department of Ambulatory Care and Community Medicine, University of Lausanne, Switzerland
    Swiss Med Wkly 138:31-7. 2008
    ..The technical aspects required for performance of the tests must be considered...
  2. pmc Accelerated decline in lung function in smoking women with airway obstruction: SAPALDIA 2 cohort study
    Sara H Downs
    Institute of Social and Preventive Medicine, University of Basle, Basle, Switzerland
    Respir Res 6:45. 2005
    ..The aim was to determine if effects from smoking on lung function measured over 11 years differ between men and women...
  3. ncbi Active and passive screening for tuberculosis in Vaud Canton, Switzerland
    Murielle Monney
    University Medical Policlinic, Lausanne, Switzerland
    Swiss Med Wkly 135:469-74. 2005
    ....
  4. ncbi Current issues in the management of tuberculosis in Europe
    J P Zellweger
    Swiss Lung Association, Berne, Switzerland
    Panminerva Med 55:145-55. 2013
    ..Medical doctors are encouraged to share their questions with experts and refer to existing Guidelines...
  5. doi [Multidrug resistant tuberculosis -- its extent, hazard and possible solutions]
    J P Zellweger
    Centre de compétence tuberculose, ligue pulmonaire suisse, 14c, Südbahnhofstrasse, 3000 Berne 14, Suisse
    Rev Mal Respir 28:1025-33. 2011
    ..This can have implications for the modification and development of national strategies. The future of the fight against tuberculosis depends in part on the success of strategies to combat the development and spread of MDR-TB...
  6. pmc Reference values for methacholine reactivity (SAPALDIA study)
    Pierre Yves Jayet
    Service of Pulmonology, University Hospital Lausanne, Switzerland
    Respir Res 6:131. 2005
    ..We derived reference equations depending on individual characteristics (i.e., sex, age, baseline lung function) for relevant percentiles of the methacholine two-point dose-response slope...
  7. pmc Clinical presentation, demographics and outcome of tuberculosis (TB) in a low incidence area: a 4-year study in Geneva, Switzerland
    Omar Kherad
    Department of Internal Medicine Geneva University Hospitals and University of Geneva, Geneva, Switzerland
    BMC Infect Dis 9:217. 2009
    ..The aim of this study was to describe clinical and social characteristics of patients with TB and their outcome in a low incidence area with a high immigration rate...
  8. ncbi Tobacco and tuberculosis
    J P Zellweger
    Department of Aambulatory Care and Community Medicine, University of Lausanne, Switzerland
    Monaldi Arch Chest Dis 69:83-5. 2008
    ..Therefore, medical advice and counselling in smoking cessation is an important activity for all care providers engaged in management of TB...
  9. ncbi Bupropion SR vs placebo for smoking cessation in health care professionals
    Jean Pierre Zellweger
    University Medical Policlinic, 10011 Lausanne, Switzerland
    Am J Health Behav 29:240-9. 2005
    ..To evaluate bupropion SR for smoking cessation in physicians and nurses...
  10. ncbi Intra-observer and overall agreement in the radiological assessment of tuberculosis
    J P Zellweger
    University Medical Outpatient Department, University Hospital, Lausanne, Switzerland
    Int J Tuberc Lung Dis 10:1123-6. 2006
    ..To assess the intra-observer and overall agreement in the interpretation of chest X-rays (CXRs) performed for detecting tuberculosis (TB) among immigrants in Switzerland...
  11. ncbi Contact tracing using a new T-cell-based test: better correlation with tuberculosis exposure than the tuberculin skin test
    J P Zellweger
    University Medical Outpatient Department, Bugnon 44, 1011 Lausanne, Switzerland
    Int J Tuberc Lung Dis 9:1242-7. 2005
    ..Residential institution for alcoholics in Switzerland...
  12. ncbi [HIV and tuberculosis: new perspectives for diagnosis and treatment]
    Jean Pierre Zellweger
    PMU, 1011 Lausanne
    Rev Med Suisse 2:2616-9. 2006
    ..Some national programmes have addressed this challenge with initial success, as demonstrated by Malawi and Benin, this last country with support from Swiss authorities...
  13. ncbi [Tuberculosis and tobacco: meeting of two epidemics]
    Jean Pierre Zellweger
    Rev Med Suisse 4:2576-8, 2580. 2008
    ..Medical counselling and tobacco control policy are now regarded as important for all health care workers involved in tuberculosis management...
  14. ncbi [Why do not all smokers stop smoking?]
    Jean Pierre Zellweger
    Pneumologie FMH, Fribourg
    Ther Umsch 67:399-402. 2010
    ..The reasons why they do not consider stopping are multiple. The expectations and fears of the smokers must be known to the family doctor so that he or she can offer an individualized counseling...
  15. ncbi Treatment of tuberculosis
    Jean Pierre Zellweger
    Department of Ambulatory Care and Community Medicine, University of Lausanne, Rue du Bugnon 44, 1011 Lausanne, Switzerland
    Expert Rev Respir Med 1:85-97. 2007
    ..This review is intended primarily for physicians unfamiliar with the management of tuberculosis...
  16. ncbi Electronic monitoring of long-term use of the nicotine nasal spray and predictors of success in a smoking cessation program
    Marie Paule Schneider
    Medical Outpatient Clinic, University Hospital, Lausanne, Switzerland
    Nicotine Tob Res 5:719-27. 2003
    ..Mean daily consumption of the nicotine nasal spray remained lower than expected in most participants, particularly in failures...
  17. ncbi Screening and treatment for latent tuberculosis infection among asylum seekers entering Switzerland
    Eric Breuss
    University Medical Policlinic, Rue César Roux 19, CH 1005 Lausanne, Switzerland
    Swiss Med Wkly 132:197-200. 2002
    ..To evaluate the compliance of doctors and patients with the current recommendations for screening and preventive treatment of immigrants with a positive tuberculin skin test (TST) suggestive of latent tuberculosis infection (LTBI)...
  18. pmc Screening for latent tuberculosis infection among undocumented immigrants in Swiss healthcare centres; a descriptive exploratory study
    Patrick Bodenmann
    Department of Ambulatory Care and Community Medicine, University of Lausanne, Switzerland
    BMC Infect Dis 9:34. 2009
    ..The objective of this study is to assess the prevalence of latent tuberculosis infection (LTBI) and adherence to preventive treatment in a population of undocumented immigrant patients...
  19. ncbi Active screening for pulmonary tuberculosis among immigrants by chest x-ray at the Swiss border
    Christian Mathez
    Department of Ambulatory Care and Community Medicine, University of Lausanne, Lausanne
    Swiss Med Wkly 137:649-54. 2007
    ..To assess the number of immigrants with pulmonary tuberculosis detected by chest x-ray screening at the Swiss border...
  20. ncbi Influence of long-term smoking reduction on health risk markers and quality of life
    Chris T Bolliger
    Respiratory Division, Department of Internal Medicine, University Hospital, Basle, Switzerland
    Nicotine Tob Res 4:433-9. 2002
    ....
  21. doi Novel screening tools for latent tuberculosis: time to leave an old friend?
    Peter M Villiger
    Department of Rheumatology and Clinical Immunology Allergology, University Hospital, University of Bern CH 3010, Switzerland
    Curr Opin Rheumatol 21:238-43. 2009
    ..The performance of diagnostic testing for latent tuberculosis infection in patients with rheumatic diseases will be discussed...
  22. ncbi Directly observed therapy for tuberculosis in a low prevalence region: first experience at the Tuberculosis Dispensary in Lausanne
    J Deruaz
    TB Dispensary, University Medical Policlinic, Lausanne, Switzerland
    Swiss Med Wkly 134:552-8. 2004
    ..Evaluation of first experience of the directly observed therapy (DOT) programme for tuberculosis introduced in the Canton of Vaud in 1997...
  23. ncbi Perception of the damaging effects of smoking, and brief cessation counselling by doctors
    P Bodenmann
    Medical Outpatient Clinic, University Hospital, Lausanne, Switzerland
    Swiss Med Wkly 135:256-62. 2005
    ..Smoking cessation counselling by a doctor was only given to a minority of patients, but such counselling seemed irrespective of nationality...
  24. ncbi Epidemiological and economical impact of tuberculosis in an adolescent girl in Lausanne (Switzerland)
    E Zangger
    , Lausanne, Switzerland
    Swiss Med Wkly 131:418-21. 2001
    ..3) Contact tracing and the high costs involved could have been avoided if the patient had received preventive chemotherapy upon her arrival in Switzerland...
  25. ncbi [Human costs of tobacco dependence]
    Marco Vannotti
    Policlinique médicale universitaire PMU, Service de Psychiatrie de Liaison, Lausanne, Suisse
    Rev Med Suisse Romande 122:101-4. 2002
    ..Such economic study may contribute to better understand smokers' concerns and beliefs and to improve effective strategies for smoking cessation in primary care...
  26. pmc Factors associated with latent tuberculosis among asylum seekers in Switzerland: a cross-sectional study in Vaud County
    Apostolos Sarivalasis
    Department of Ambulatory Care and Community Medicine PMU, Rue du Bugnon 44, 1011, Lausanne, Vaud, Switzerland
    BMC Infect Dis 12:285. 2012
    ..As the screening with Interferon Gamma Release Assay (IGRA) is costly, the objective of this study was to assess which factors were associated with LTBI and to define a score allowing the selection of AS with the highest risk of LTBI...
  27. pmc Use of nicotine substitute prescribed at hourly plus ab libitum intake or ad libitum for heavy smokers willing to quit: a randomized controlled trial
    Laurent Rey
    Department of Ambulatory Care and Community Medicine, University of Lausanne, Switzerland
    Subst Abuse Treat Prev Policy 4:12. 2009
    ..To assess the impact of instructional guidance in the regular use of use nicotine nasal spray (NNS) on the true use of NNS during the first three weeks of smoking cessation for heavy smokers who are willing to quit...
  28. ncbi Indeterminate test results of T-SPOT.TB performed under routine field conditions
    P Beffa
    Dept of Ambulatory Care and Community Medicine, University of Lausanne, Rue du Bugnon 44, 1011 Lausanne, Switzerland
    Eur Respir J 31:842-6. 2008
    ..The conditions of transportation may influence the incidence of indeterminate test results...
  29. ncbi [Reduction of cigarette consumption: an intermediate stage before a total stop?]
    J P Zellweger
    PMU, Lausanne
    Rev Med Suisse 2:1701-3. 2006
    ..Smoking reduction can be offered to some smokers with smoking-related diseases as a transition before complete cessation. It can be obtained more easily with the use of nicotine replacement therapy...
  30. pmc Smoking reduction with oral nicotine inhalers: double blind, randomised clinical trial of efficacy and safety
    C T Bolliger
    Respiratory Division, Department of Internal Medicine, University Hospital, 4031 Basle, Switzerland
    BMJ 321:329-33. 2000
    ..To determine whether use of an oral nicotine inhaler can result in long term reduction in smoking and whether concomitant use of nicotine replacement and smoking is safe...
  31. ncbi [Smoking cessation intervention: 2006 update]
    J Cornuz
    PMU, Lausanne
    Rev Med Suisse 2:1683-8. 2006
    ..The safety of nicotine replacement therapy for patients with cardiovascular disorders has been confirmed. Among new pharmacological approaches, varenicline, rimonabant, topiramate and nicotine vaccine all appear promising...
  32. ncbi Anti-Smoking therapies: is harm reduction a viable alternative to smoking cessation?
    J P Zellweger
    University Medical Policlinic, Lausanne, Switzerland
    Drugs 61:1041-4. 2001
    ..From available studies, it does not seem that a period of sustained smoking reduction decreases the chance of future cessation, it may even increase it...
  33. ncbi The oxygen concentrator: an appropriate technology for treating hypoxaemic children in developing countries
    A Perrelet
    Department of Paediatrics, Hôpital de l enfance, Lausanne, Switzerland
    Int J Tuberc Lung Dis 8:1138-41. 2004
    ..A strategy including technical training, maintenance and monitoring should be adopted. Corrective actions were undertaken in Ndioum, and several concentrators are now being used on a regular basis...
  34. ncbi T-SPOT.TB: an in vitro diagnostic assay measuring T-cell reaction to Mycobacterium tuberculosis-specific antigens
    Antona J Wagstaff
    Adis International Inc, Yardley, Pennsylvania 19067, USA
    Mol Diagn Ther 10:57-63; discussion 64-5. 2006
    ..Unlike the TST, the RD1 ELISPOT assay is not confounded by bacille Calmette-Guérin vaccination...
  35. ncbi [Of what value is an antitubercular dispensary in our age?]
    Jean Pierre Zellweger
    Policlinique Médicale Universitaire Rue César Roux 19 1005 Lausanne
    Rev Med Suisse Romande 122:475-7. 2002
    ..Several studies have been conducted on the clinical and epidemiologial aspects of TB and about the management of the disease in risk groups, mainly migrants...
  36. ncbi Outcome of treatment of pulmonary tuberculosis in Switzerland in 1996
    Peter Helbling
    Swiss Federal Office of Public Health, Bern
    Swiss Med Wkly 132:517-22. 2002
    ..Adequate treatment of pulmonary tuberculosis cures patients and reduces transmission. The study assesses treatment outcomes under current conditions in Switzerland...
  37. ncbi Risk factors for positive tuberculin skin tests among migrant and resident children in Lausanne, Switzerland
    E Collet
    University Children s Hospital, ch de Montétan 16, CH 1000 Lausanne 7, Switzerland
    Swiss Med Wkly 135:703-9. 2005
    ..Ambulatory paediatric clinic in Lausanne, Switzerland, a country with a significant proportion of tuberculosis (TB) among immigrants...
  38. ncbi Five-day plan for smoking cessation using group behaviour therapy
    Mylena Frikart
    University Institute of Social and Preventive Medicine, Avenue de la Gare 6, CH 1003 Lausanne, Switzerland
    Swiss Med Wkly 133:39-43. 2003
    ..7% vs. 18.9%, p = 0.049). Stress was the most common cause of relapse. The FDP appears to be an effective smoking cessation therapy. Propositions are made in order to improve the success rate of future sessions...
  39. ncbi [Tobacco use disorder and use of nicotine substitutes during pregnancy and post-partum]
    Jacques Cornuz
    Département de médecine et unité de prévention, CHUV, Lausanne
    Rev Med Suisse Romande 122:305-7. 2002
  40. ncbi Nicotine replacement to reduce cigarette consumption in smokers who are unwilling to quit: a randomized trial
    Jean Francois Etter
    Institute of Social and Preventive Medicine, University of Geneva, Switzerland
    J Clin Psychopharmacol 22:487-95. 2002
    ..Nicotine treatment for smoking reduction had no detectable impact on smoking cessation...
  41. ncbi Predictors of methacholine responsiveness in a general population
    Joel Schwartz
    Harvard School of Public Health, USA
    Chest 122:812-20. 2002
    ..This study aims to quantify the relative importance of different predictors of responsiveness such as age, sex, airway caliber, smoking and atopic status, and potential interactions deserving further investigation...
  42. ncbi [Bilateral micro-nodular pulmonary infiltrate in an African young man]
    Salimé Saber
    Rev Med Suisse Romande 123:499-500. 2003
  43. ncbi Successful embolization of Rasmussen's aneurysm for severe haemoptysis
    Pierre Yves Jayet
    Swiss Med Wkly 134:705-6. 2004
  44. ncbi Follow-up of the Swiss Cohort Study on Air Pollution and Lung Diseases in Adults (SAPALDIA 2) 1991-2003: methods and characterization of participants
    Ursula Ackermann-Liebrich
    Institute of Social and Preventive Medicine, University of Basel, Switzerland
    Soz Praventivmed 50:245-63. 2005
    ..The Swiss Cohort Study on Air Pollution and Lung Diseases in Adults (SAPALDIA) was designed to investigate the health effects from long-term exposure to air pollution...
  45. ncbi Screening for tuberculosis infection before the initiation of an anti-TNF-alpha therapy
    Christoph Beglinger
    Abteilung für Gastroenterologie, Universitatsspital Basel, Basel, Switzerland
    Swiss Med Wkly 137:620-2. 2007
  46. ncbi [Epidemiogy and treatment of tuberculosis in Switzerland]
    Peter Helbling
    Office fédéral de la santé publique Maladies transmissibles, 3003 Berne
    Rev Med Suisse 2:2276-8, 2280-1. 2006
    ..Discussion with a specialist is often warranted. A follow-up by the Swiss Pulmonary Association is recommended to prevent the patient from defaulting from treatment...
  47. ncbi Diagnostic yield of sputum, induced sputum, and bronchoscopy after radiologic tuberculosis screening
    Otto D Schoch
    Pneumology, Kantonsspital St Gallen, CH 9007 St Gallen, Switzerland
    Am J Respir Crit Care Med 175:80-6. 2007
    ..To assess feasibility and yield of diagnostic procedures after active case finding for tuberculosis with radiologic screening at the three main entry points for asylum seekers to Switzerland...
  48. ncbi Reduced exposure to PM10 and attenuated age-related decline in lung function
    Sara H Downs
    Institute of Social and Preventive Medicine, University of Basel, Basel, Switzerland
    N Engl J Med 357:2338-47. 2007
    ..Air pollution has been associated with impaired health, including reduced lung function in adults. Moving to cleaner areas has been shown to attenuate adverse effects of air pollution on lung function in children but not in adults...